期刊文献+

慢性乙型肝炎需要长期、有效地抗病毒治疗 被引量:2

下载PDF
导出
摘要 目前研究证明.持续高HBV载量是慢性乙型肝炎(CHB)病情进展的主要病因.通过对26个前瞻性研究荟萃分析显示.血清HBVDNA水平与肝组织病变严重程度及活动性呈正相关。经抗病毒治疗后.随着HBVDNA水平下降.肝病活动指数(HAt)也明显下降,因此,在CHB时,病毒载量可以衡量组织病变的严重和活动程度。台湾学者证明持续高载量HBVDNA,
作者 斯崇文
出处 《药品评价》 CAS 2007年第3期138-139,共2页 Drug Evaluation
  • 引文网络
  • 相关文献

参考文献7

  • 1Mommeja-Marin H,Mondon E,Blum RM,et al.Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection:Analysis and review of the literature[].Hepatology.2003
  • 2Chen CJ,Yang HI,Su j,et al.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[].The Journal of The American Medical Association.2006
  • 3Lawrence S,Thabut D,Zoulim F,et al.Sequential treatment with lamivudine and interferon monotherapies in patents with chronic hepatitis B not responding to interferon alone:Results of a pilot study[].Hepatology.2001
  • 4Chen CJ,Yang HI,Su J,et al.Viral load is a strong predictor of liver cirrhosis risk in people chronically infected with hepatitis B virus regardless of hepatitis B e antigen status[].Journal of Hepatology.2005
  • 5Lok ASF,McMahon BJ.AASLD practice guidline:Chronic hepatitis B[].Hepatology.2007
  • 6Liaw YF,Leung N,Guan R,et al.Asian-Pacific consensus statement on management of chronic hepatitis B:An update[].Journal of Gastroenterology and Hepatology.2003
  • 7Di Bisceglie AM,Lai CL,Gane E,et al.Telbivudine Globe trialmaximal early suppression is predictive of optimal two-year efficacy in nucleoside-treated hepatitis B patients[].Hepatology.

同被引文献9

引证文献2

二级引证文献7

;
使用帮助 返回顶部